Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Wendel HG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Portelinha A; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Wang S; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Parsa S; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Jiang M; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Gorelick AN; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Mohanty S; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Sharma S; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center , New York, NY, USA., Berishaj M; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Zhao C; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA., Heward J; Nucleome Therapeutics , Oxford, UK., Aryal NK; Bioscience, Early Oncology R&D, AstraZeneca , Waltham, MA, USA., Tavana O; Bioscience, Early Oncology R&D, AstraZeneca , Waltham, MA, USA., Wen J; Division of Genome Sciences and Cancer, The John Curtin School of Medical Research, The Australian National University and Australian Research Council Centre of Excellence for the Mathematical Analysis of Cellular Systems, Canberra, Australia., Fitzgibbon J; Haematology R&D, AstraZeneca , Waltham, MA, USA., Dogan A; Departments of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Younes A; Haematology R&D, AstraZeneca , New York, NY, USA., Melnick AM; Hematology and Oncology Division, Medicine Department, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA., Wendel HG; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center , New York, NY, USA.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2024 Oct 07; Vol. 221 (10). Date of Electronic Publication: 2024 Sep 05.
Autor:
Boyer JA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA., Sharma M; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Dorso MA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Mai N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Amor C; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reiter JM; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Kannan R; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gadal S; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Xu J; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Miele M; Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li Z; Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen X; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Chang Q; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Pareja F; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Worland S; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Warner D; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Sperry S; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Chiang GG; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Thompson PA; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Yang G; The Organic Synthesis Core Facility, MSK, New York, NY, USA., Ouerfelli O; The Organic Synthesis Core Facility, MSK, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Wendel HG; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Rosen N; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 May 11. Date of Electronic Publication: 2024 May 11.
Autor:
Xu D; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK. danmei.xu@nhs.net.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK. danmei.xu@nhs.net.; Centre for Haematology, Imperial College London, Hammersmith Hospital, Du Cane Road, London, UK. danmei.xu@nhs.net.; Oxford Cancer and Haematology centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, UK. danmei.xu@nhs.net., Bewicke-Copley F; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK., Close K; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK., Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK., Gale RP; Centre for Haematology, Imperial College London, Hammersmith Hospital, Du Cane Road, London, UK., Apperley J; Centre for Haematology, Imperial College London, Hammersmith Hospital, Du Cane Road, London, UK., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Merck and Co., Rahway, NJ, USA., Wendel HG; Memorial Sloan-Kettering Cancer Center, Cancer Biology & Genetics, New York, NY, 10065, USA., Fitzgibbon J; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Feb 13; Vol. 14 (1), pp. 29. Date of Electronic Publication: 2024 Feb 13.
Autor:
Portelinha A; Memorial Sloan Kettering Cancer Center., Wendel HG; Memorial Sloan Kettering Cancer Center.
Publikováno v:
Blood [Blood] 2023 Mar 30; Vol. 141 (13), pp. 1502-1503.
Autor:
Schiffmann S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.; Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe-University Hospital Frankfurt am Main, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany., Henke M; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany., Seifert M; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany., Ulshöfer T; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany., Roser LA; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany., Magari F; Institute of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany., Wendel HG; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Grünweller A; Institute of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany., Parnham MJ; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.; EpiEndo Pharmaceuticals ehf, Bjargargata 1, 102 Reykjavik, Iceland.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 20; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 20.